Oncocross is a biotechnology company specializing in precision medicine for cancer treatment. The company focuses on developing advanced diagnostic solutions that enable personalized therapy selection for cancer patients. By utilizing innovative technologies, Oncocross aims to enhance treatment outcomes through tailored approaches based on individual tumor profiles. Their offerings include comprehensive genomic analysis and insights that support oncologists in making informed treatment decisions.